In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.
The study, led by TSRI Associate Professor Susana Valente, was published online Oct. 17 before print in the journal Cell Reports.
“No other anti-retroviral used in the clinic today is able to completely suppress viral production in infected cells in vivo,” Valente said. “When combining this drug with the standard cocktail of anti-retrovirals used to suppress infection in humanized mouse models of HIV-1 infection, our study found a drastic reduction in virus RNA present—it is really the proof-of-concept for a ‘functional cure.’”
Valente, a pioneer in this new approach, calls it “Block-and-Lock”—the approach blocks reactivation of the virus in cells, even during treatment interruptions, and locks HIV into durable state of latency.
Valente and her colleagues use a derivative of a natural compound called didehydro-Cortistatin A (dCA), which blocks replication in HIV-infected cells by inhibiting the viral transcriptional activator, called Tat, halting viral production, reactivation and replenishment of the latent viral reservoir.
“Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation,” Valente said. “It’s important to note that our study uses the maximum tolerable dose of the drug—with virtually no side effects.”
The scientists studied the combination therapy in a mouse model of HIV latency and persistence. Once the combined treatment regimen was halted, viral rebound was delayed up to 19 days, compared with just seven days in mouse models receiving only anti-retroviral treatment.
“This demonstrates the potential of ‘block-and-lock’ strategies,” said TSRI Research Associate Cari F. Kessing, co-first author of the study. “This study shows that a ‘functional cure’ approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption.”
“In half of the dCA treated mice, the virus was undetectable for 16 days after all treatment was halted,” said the University of North Carolina’s Christopher Nixon, another first author.
“We blocked Tat, and the cell’s machinery did the rest,” said TSRI Research Associate Chuan Li, a coauthor of the study. “The result was that the HIV promoter becomes repressed.”
Valente pointed out that the animal models were exposed to just a single month of treatment. “That’s a relatively short period of time,” she said. “We think longer treatments will result in longer, or even permanent, rebound delays. The question is how long? We’re studying that now.”
Because any viral rebound of HIV comes with a host of adverse effects, Valente noted, blocking that rebound would automatically reduce those effects.
“This is the only class of drugs that stops infected cells from making viruses outright,” said Valente. “All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production.”
The Latest on: HIV
- Bulk medication to be given to HIV positive personson March 29, 2020 at 6:49 am
The district AIDS Prevention and Control Unit has decided to give out bulk medication to HIV positive persons because of COVID-19 pandemic. The people would receive enough medication for two to three ...
- Health D-G: Malaria, HIV drugs can be used to treat Covid-19on March 28, 2020 at 9:09 pm
Several drugs used for the treatment of malaria and HIV in Malaysia can also be used to treat Covid-19 patients, said Health director-general Datuk Dr Noor Hisham Abdullah.
- Everyone who is HIV-positive deserves love, and equal protection under Missouri lawon March 28, 2020 at 3:00 am
Anyone who is wise will tell you that it’s important to show up for our loved ones every day. I’ve learned to celebrate the fact that each one of us is deserving of love. As a gay man, that’s ...
- A new way to study HIV's impact on the brainon March 27, 2020 at 3:21 pm
Half of HIV patients have HIV-associated neurocognitive disorders (HAND), which can manifest in a variety of ways, from forgetfulness and confusion to behavior changes and motor deficiencies. To ...
- Opinion: The Coronavirus And HIV Are Different Pandemics, But The Lessons Are The Sameon March 27, 2020 at 2:24 pm
San Francisco's world-leading public health department is a byproduct of our multidecade fight against AIDS. The lessons we learned then are just as vital today.
- Potential Impact of Targeted HIV Pre-Exposure Prophylaxis Uptake Among Male Sex Workerson March 27, 2020 at 3:13 am
Little is known about the potential population-level impact of HIV pre-exposure prophylaxis (PrEP) use among cisgender male sex workers (MSWs), a high-risk subset of cisgender men who have sex with ...
- Coronavirus Treatment: HIV Drug Used To Cure COVID-19 Positive British National In Indiaon March 26, 2020 at 8:57 pm
As the world battles the coronavirus pandemic, doctors throughout the world have been experimenting with several drugs to treat coronavirus patients. Doctors in the southern India state of Kerala have ...
- Senate stimulus plan includes $155 million for HIV careon March 26, 2020 at 1:31 pm
The $2 trillion stimulus package approved by the Senate on Wednesday includes $155 million in funding for people living with HIV who may be affected by the global coronavirus pandemic. The full text ...
- HIV-positive prison inmate in Ohio argues to state Supreme Court that imprisonment during coronavirus is a death sentenceon March 26, 2020 at 10:15 am
CLEVELAND, Ohio — An HIV-positive Ohio prison inmate is arguing to the state’s high court that remaining imprisoned during the coronavirus pandemic could be a death sentence for him and constitutes ...
- Jewel Thais-Williams Used Her Landmark Black LGBTQ Club to Support People with HIVon March 26, 2020 at 7:33 am
In addition to owning the discotheque, Thais-Williams served as a founder or cofounder of several organizations, including the Minority AIDS Project and Rue’s House, which provided vital services to ...
via Google News and Bing News